keyword
https://read.qxmd.com/read/38727755/molecular-characterization-and-distribution-of-motilin-and-motilin-receptor-in-the-japanese-medaka-oryzias-latipes
#1
JOURNAL ARTICLE
Morio Azuma, Norifumi Konno, Ichiro Sakata, Taka-Aki Koshimizu, Hiroyuki Kaiya
Motilin (MLN) is a peptide hormone originally isolated from the mucosa of the porcine intestine. Its orthologs have been identified in various vertebrates. Although MLN regulates gastrointestinal motility in tetrapods from amphibians to mammals, recent studies indicate that MLN is not involved in the regulation of isolated intestinal motility in zebrafish, at least in vitro. To determine the unknown function of MLN in teleosts, we examined the expression of MLN and the MLN receptor (MLNR) at the cellular level in Japanese medaka (Oryzias latipes)...
May 10, 2024: Cell and Tissue Research
https://read.qxmd.com/read/38723597/gut-dopamine-kick-how-gut-microbes-turn-on-host-receptors-to-fight-pathogens
#2
JOURNAL ARTICLE
Eran Gutman, Yael Litvak
Common nutrients in our diet often affect our health through unexpected mechanisms. In a recent issue of Nature, Scott et al. show gut microbes convert dietary tryptophan into metabolites activating intestinal dopamine receptors, which can block attachment of bacterial pathogens to host cells.
May 8, 2024: Cell Host & Microbe
https://read.qxmd.com/read/38656158/multicomponent-pathogen-mimicking-nanoparticles-induce-intestinal-immune-responses-against-paratuberculosis
#3
JOURNAL ARTICLE
Yiduo Liu, Meizhen Long, Yuanzhi Wang, Zhengmin Liang, Yuhui Dong, Mengjin Qu, Xin Ge, Yue Nan, Yulan Chen, Xiangmei Zhou
Given the worldwide problem posed by enteric pathogens, the discovery of safe and efficient intestinal adjuvants combined with novel antigen delivery techniques is essential to the design of mucosal vaccines. In this work, we designed poly (lactic-co-glycolic acid) (PLGA)-based nanoparticles (NPs) to codeliver all-trans retinoic acid (atRA), novel antigens, and CpG. To address the insolubility of the intestinal adjuvant atRA, we utilized PLGA to encapsulate atRA and form a "nanocapsid" with polydopamine. By leveraging polydopamine, we adsorbed the water-soluble antigens and the TLR9 agonist CpG onto the NPs' surface, resulting in the pathogen-mimicking PLPCa NPs...
April 24, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38629943/current-and-emerging-pharmacotherapy-for-the-treatment-of-gastroparesis
#4
REVIEW
M Ammar Kalas, Irene Sarosiek, Richard W McCallum
INTRODUCTION: Gastroparesis is a chronic disorder characterized by decreased gastric emptying and presents with nausea, vomiting, and abdominal pain which impacts patients' quality of life greatly. The treatment modalities available for gastroparesis have been expanding over the past 2 decades. Currently there are multiple options available for gastroparesis albeit with only one FDA approved medication until June of 2021. AREAS COVERED: We review the different treatments available for gastroparesis and discuss the recently FDA approved intranasal formulation of metoclopramide...
April 17, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38626866/mechanisms-of-neurocentral-eyestalk-intestinal-immunotoxicity-in-whiteleg-shrimp-litopenaeus-vannamei-under-ammonia-nitrogen-exposure
#5
JOURNAL ARTICLE
Ruixue Tong, Yaobing Li, Xin Yu, Ning Zhang, Qilong Liao, Luqing Pan
Ammonia-N, as the most toxic nitrogenous waste, has high toxicity to marine animals. However, the interplay between ammonia-induced neuroendocrine toxicity and intestinal immune homeostasis has been largely overlooked. Here, a significant concordance of metabolome and transcriptome-based "cholinergic synapse" supports that plasma metabolites acetylcholine (ACh) plays an important role during NH4 Cl exposure. After blocking the ACh signal transduction, the release of dopamine (DA) and 5-hydroxytryptamine (5-HT) in the cerebral ganglia increased, while the release of NPF in the thoracic ganglia and NE in the abdominal ganglia, and crustacean hyperglycemic hormone (CHH) and neuropeptide F (NPF) in the eyestalk decreased, finally the intestinal immunity was enhanced...
April 14, 2024: Environmental Pollution
https://read.qxmd.com/read/38625529/roles-of-nutrients-in-the-brain-development-cognitive-function-and-mood-of-dogs-and-cats
#6
JOURNAL ARTICLE
Guoyao Wu
The brain is the central commander of all physical activities and the expression of emotions in animals. Its development and cognitive health critically depend on the neural network that consists of neurons, glial cells (namely, non-neuronal cells), and neurotransmitters (communicators between neurons). The latter include proteinogenic amino acids (e.g., L-glutamate, L-aspartate, and glycine) and their metabolites [e.g., γ-aminobutyrate, D-aspartate, D-serine, nitric oxide, carbon monoxide, hydrogen sulfide, and monoamines (e...
2024: Advances in Experimental Medicine and Biology
https://read.qxmd.com/read/38570412/the-gut-microbiota-in-parkinson-disease-interactions-with-drugs-and-potential-for-therapeutic-applications
#7
JOURNAL ARTICLE
Elisa Menozzi, Anthony H V Schapira
The concept of a 'microbiota-gut-brain axis' has recently emerged as an important player in the pathophysiology of Parkinson disease (PD), not least because of the reciprocal interaction between gut bacteria and medications. The gut microbiota can influence levodopa kinetics, and conversely, drugs administered for PD can influence gut microbiota composition. Through a two-step enzymatic pathway, gut microbes can decarboxylate levodopa to dopamine in the small intestine and then dehydroxylate it to m-tyramine, thus reducing availability...
April 3, 2024: CNS Drugs
https://read.qxmd.com/read/38522241/the-effects-of-nardosinone-on-levodopa-intervention-in-the-treatment-of-parkinson-s-disease
#8
JOURNAL ARTICLE
Mengmeng Liu, Jingwen Xue, Yuxin Cao, Zhuangzhuang Hao, Yuqing Wang, Jiayuan Li, Tingyue Jiang, Jinli Shi
BACKGROUND: The roots and rhizomes of Nardostachys jatamansi DC. are reported to be useful for the treatment of Parkinson's disease (PD). Previous research has also shown that Nardosinone, the main active component isolated from Nardostachys jatamansi DC., exhibits the potential to treat PD. AIM OF THE STUDY: To investigate how the effects of Nardosinone could assist levodopa in the treatment of PD, how this process changes the intestinal flora, and to explore the effective forms of Nardosinone in the intestinal flora...
May 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38521816/developmental-expression-of-catecholamine-system-in-the-human-placenta-and-rat-fetoplacental-unit
#9
JOURNAL ARTICLE
Rona Karahoda, Veronika Vachalova, Ramon Portillo, Filip Mahrla, Mireia Viñas-Noguera, Cilia Abad, Frantisek Staud
Catecholamines norepinephrine and dopamine have been implicated in numerous physiological processes within the central nervous system. Emerging evidence has highlighted the importance of tightly regulated monoamine levels for placental functions and fetal development. However, the complexities of synthesis, release, and regulation of catecholamines in the fetoplacental unit have not been fully unraveled. In this study, we investigated the expression of enzymes and transporters involved in synthesis, degradation, and transport of norepinephrine and dopamine in the human placenta and rat fetoplacental unit...
March 23, 2024: Scientific Reports
https://read.qxmd.com/read/38517270/discovery-of-a-gut-bacterial-metabolic-pathway-that-drives-%C3%AE-synuclein-aggregation
#10
JOURNAL ARTICLE
Lizett Ortiz de Ora, Julia M Balsamo, Kylie S Uyeda, Elizabeth N Bess
Parkinson's disease (PD) etiology is associated with aggregation and accumulation of α-synuclein (α-syn) proteins in midbrain dopaminergic neurons. Emerging evidence suggests that in certain subtypes of PD, α-syn aggregates originate in the gut and subsequently spread to the brain. However, mechanisms that instigate α-syn aggregation in the gut have remained elusive. In the brain, the aggregation of α-syn is induced by oxidized dopamine. Such a mechanism has not been explored in the context of the gastrointestinal tract, a niche harboring 46% of the body's dopamine reservoirs...
March 22, 2024: ACS Chemical Biology
https://read.qxmd.com/read/38488234/huanglian-banxia-promotes-gastric-motility-of-diabetic-rats-by-modulating-brain-gut-neurotransmitters-through-mapk-signaling-pathway
#11
JOURNAL ARTICLE
Wei Chen, Qiong Chen, Jiayi Huang, Xianmin Shen, Lurong Zhang, Guorong Jiang, Tingting Wu, Fei Wang, Xudong Cheng
BACKGROUND: Gastric motility disorder is an increasingly common problem among people with diabetes. Neurotransmitters have been recognized as critical regulators in the process of gastric motility. Previous study has shown that herb pair huanglian-banxia (HL-BX) can improve gastric motility, but the underlying mechanism is still unclear. The aim of this study was to further investigate the role of HL-BX in modulating brain-gut neurotransmission to promote gastric motility in diabetic rats, and to explore its possible mechanism...
March 15, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38480886/dopamine-receptor-d2-confers-colonization-resistance-via-microbial-metabolites
#12
JOURNAL ARTICLE
Samantha A Scott, Jingjing Fu, Pamela V Chang
The gut microbiome has major roles in modulating host physiology. One such function is colonization resistance, or the ability of the microbial collective to protect the host against enteric pathogens1-3 , including enterohaemorrhagic Escherichia coli (EHEC) serotype O157:H7, an attaching and effacing (AE) food-borne pathogen that causes severe gastroenteritis, enterocolitis, bloody diarrhea and acute renal failure4,5 (haemolytic uremic syndrome). Although gut microorganisms can provide colonization resistance by outcompeting some pathogens or modulating host defence provided by the gut barrier and intestinal immune cells6,7 , this phenomenon remains poorly understood...
March 13, 2024: Nature
https://read.qxmd.com/read/38460175/levodopa-carbidopa-entacapone-intestinal-gel-in-advanced-parkinson-disease-a-multicenter-real-life-experience
#13
JOURNAL ARTICLE
József Attila Szász, Adriana Octaviana Dulamea, Viorelia Adelina Constantin, Dafin Fior Mureşanu, Lăcrămioara Perju Dumbravă, Cristina Tiu, Dragoş Cătălin Jianu, Mihaela Simu, Amalia Ene, Any Axelerad, Cristian Falup-Pecurariu, Mihaela Lungu, Adina Gabriela Danci, Monica Sabau, Ştefan Strilciuc, Bogdan Ovidiu Popescu
BACKGROUND: For Parkinson disease (PD) patients who have been diagnosed with advanced disease that can no longer be effectively controlled with optimized oral or transdermal medications, a range of device-aided therapies (DAT) are available, comprising either deep brain stimulation or infusion therapies providing continuous dopaminergic stimulation. Levodopa-entacapone-carbidopa intestinal gel (LECIG) infusion is the latest DAT for advanced PD (APD) that was approved in Romania in 2021...
March 8, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38450172/electroacupuncture-at-st25-corrected-gut-microbial-dysbiosis-and-snpc-lipid-peroxidation-in-parkinson-s-disease-rats
#14
JOURNAL ARTICLE
Xuan-Ming Hu, Li-Zhe-Xiong Song, Zhi-Zi Zhang, Xi Ruan, Hai-Chang Li, Zhi Yu, Lin Huang
INTRODUCTION: Parkinson's disease (PD) remains one kind of a complex, progressive neurodegenerative disease. Levodopa and dopamine agonists as widely utilized PD therapeutics have not shown significant positive long-term outcomes. Emerging evidences indicate that electroacupuncture (EA) have potential effects on the therapy of nervous system disorders, particularly PD, but its specific underlying mechanism(s) remains poorly understood, leading to the great challenge of clinical application and management...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38447734/melatonin-mitigates-manganese-induced-neural-damage-via-modulation-of-gut-microbiota-metabolism-in-mice
#15
JOURNAL ARTICLE
Weifeng He, Xueting Wang, Xin Yang, Gaoman Zhang, Junrou Zhang, Li Chen, Piye Niu, Tian Chen
Manganese (Mn), a common environmental and occupational risk factor for Parkinson's disease (PD), can cause central nervous system damage and gastrointestinal dysfunction. The melatonin has been shown to effectively improve neural damage and intestinal microbiota disturbances in animal models. This research investigated the mechanism by which exogenous melatonin prevents Mn-induced neurogenesis impairment and neural damage. Here, we established subchronic Mn-exposed mice model and melatonin supplement tests to evaluate the role of melatonin in alleviating Mn-induced neurogenesis impairment...
March 4, 2024: Science of the Total Environment
https://read.qxmd.com/read/38435303/dysbiosis-of-the-gut-microbiota-and-its-effect-on-%C3%AE-synuclein-and-prion-protein-misfolding-consequences-for-neurodegeneration
#16
REVIEW
Nasir Uddin Mahbub, Md Minarul Islam, Seong-Tshool Hong, Hea-Jong Chung
Abnormal behavior of α-synuclein and prion proteins is the hallmark of Parkinson's disease (PD) and prion illnesses, respectively, being complex neurological disorders. A primary cause of protein aggregation, brain injury, and cognitive loss in prion illnesses is the misfolding of normal cellular prion proteins (PrPC ) into an infectious form (PrPSc ). Aggregation of α-synuclein causes disruptions in cellular processes in Parkinson's disease (PD), leading to loss of dopamine-producing neurons and motor symptoms...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38432923/-toward-the-complete-understanding-of-the-pathogenic-mechanism-of-clioquinol-induced-subacute-myelo-optic-neuropathy-smon
#17
JOURNAL ARTICLE
Masato Katsuyama
Clioquinol was extensively used as an amebicide to treat indigestion and diarrhea in the mid-1900s. However, it was withdrawn from the market in Japan because its use was epidemiologically linked to an increase in the incidence of subacute myelo-optic neuropathy (SMON). SMON is characterized by the subacute onset of sensory and motor disturbances in the lower extremities with occasional visual impairments, which are preceded by abdominal symptoms. Although pathological studies demonstrated axonopathy of the spinal cord and optic nerves, the underlying mechanisms of clioquinol toxicity have not been elucidated in detail...
2024: Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
https://read.qxmd.com/read/38432879/research-progress-in-the-prevention-and-treatment-of-insomnia-with-classical-prescriptions
#18
JOURNAL ARTICLE
Xiaoyu Shi, Liping Chen, Wenbin Li, Rong Wang
Insomnia is a common disease and its impact on human health cannot be ignored. At present, there are 3 main clinical treatments for insomnia, including traditional Chinese medicine treatment, sedative hypnotic drug therapy, and cognitive behavioral therapy. Traditional Chinese medicine (TCM) treatment for insomnia is widely used due to its advantages of low side effects, good efficacy, and no drug dependence. This paper summarizes the pathogenesis of insomnia in the theories of traditional Chinese and Western medicine...
October 28, 2023: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
https://read.qxmd.com/read/38412155/evidence-for-dopamine-production-and-distribution-of-dopamine-d2-receptors-in-the-equine-gastrointestinal-mucosa-and-pancreas
#19
JOURNAL ARTICLE
Nicolas C Galinelli, Nicholas J Bamford, Melody A de Laat, Martin N Sillence, Patricia A Harris, Simon R Bailey
Insulin dysregulation in horses is characterised by hyperinsulinaemia and/or tissue insulin resistance and is associated with increased risk of laminitis. There is growing evidence in other species that dopamine attenuates insulin release from the pancreas; however, this has yet to be examined in horses. The present study aimed to identify whether there are cells capable of producing or responding to dopamine within the equine gastrointestinal mucosa and pancreas. Tissue samples were collected from the stomach, small and large intestines, and pancreas of six mature horses following euthanasia...
2024: PloS One
https://read.qxmd.com/read/38369026/opening-avenues-for-treatment-of-neurodegenerative-disease-using-post-biotics-breakthroughs-and-bottlenecks-in-clinical-translation
#20
REVIEW
Bushra Bashir, Shahbaz Alam, Nikhil Khandale, Devendra Birla, Sukriti Vishwas, Narendra Kumar Pandey, Gaurav Gupta, Keshav Raj Paudel, Harish Dureja, Puneet Kumar, Thakur Gurjeet Singh, Gowthamarajan Kuppusamy, Flavia Zacconi, Terezinha de Jesus Andreoli Pinto, Muralikrishnan Dhanasekaran, Monica Gulati, Kamal Dua, Sachin Kumar Singh
Recent studies have indicated the significant involvement of the gut microbiome in both human physiology and pathology. Additionally, therapeutic interventions based on microbiome approaches have been employed to enhance overall health and address various diseases including aging and neurodegenerative disease (ND). Researchers have explored potential links between these areas, investigating the potential pathogenic or therapeutic effects of intestinal microbiota in diseases. This article provides a summary of established interactions between the gut microbiome and ND...
February 16, 2024: Ageing Research Reviews
keyword
keyword
44126
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.